Sign in
SPRB Stock Price, Chart, Stats & News
Spruce Biosciences, Inc.
Save
72.40M
Market cap
–
Current P/E
–
Forward P/E
SPRB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -73.49% |
ROE | -203.99% |
D/E | 0.02x |
Interest coverage ratio | -405.70x |
SPRB valuation
P/E | – |
P/S | – |
P/B | 1.14x |
P/CF | -1.45x |
P/FCF | -1.10x |
P/OCF | -1.45x |
PEG | -0.03x |
EV multiple | -2.40x |
About
Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatments, particularly for uncommon endocrine conditions. A central component of its therapeutic pipeline is tildacerfont, a non-steroidal drug candidate.
Similar securities
Based on sector and market capitalization
Report issue